BioSpace News Archive

BioMidwest

Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility

Alimera Sciences, Inc. announces a series of strategic transactions bolstering its balance sheet, extending its current term loan facility, and recovering value for common stockholders.

March 27, 2023
·
10 min read
QIAGEN receives approval for its net-zero carbon emissions target by Science Based Targets initiative (SBTi)SBTi has validated the QIAGEN targets to reach net-zero greenhouse gas (GHG) emissions

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its emissions reduction targets have been validated by the Science Based Targets initiative (SBTi) – a global recognition of its ambitions to honor the Paris Agreement’s climate goals.

March 27, 2023
·
6 min read
Drug Development

On Target Laboratories Announces Publication in Journal of Thoracic and Cardiovascular Surgery Phase 3 ELUCIDATE Trial of CYTALUX® (pafolacianine) Injection for Intraoperative Imaging of Lung Cancer

On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging (IMI) agents to target and illuminate cancer during surgery, today announced publication of results from the ELUCIDATE Phase 3 Trial of CYTALUX (pafolacianine) injection for use of IMI for cancer in the lung.

March 27, 2023
·
6 min read
Business

Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors

Aadi Bioscience, Inc. today announced the appointment of Mohammad Hirmand, M.D. to its Board of Directors.

March 27, 2023
·
5 min read
Business

Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes

Vertex Pharmaceuticals Incorporated today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex’s hypoimmune cell therapies for type 1 diabetes (T1D).

March 27, 2023
·
9 min read